Methotrexate in rheumatoid arthritis patients: Common side effects and leading cause of discontinuation

10^th International Conference on Orthopedics, Trauma and Rheumatology

March 08-09, 2018 London, UK

Majed Alsubaie

KSA

Posters & Accepted Abstracts: J Orthop Trauma Surg Rel Res

Abstract :

Aim: The study aims to evaluate frequency and to identify factors which may increase the discontinuation of Methotrexate (MTX) among our Rheumatoid Arthritis (RA) patients in Asir region, KSA. Method: Across sectional study was conducted in Aseer Central Hospital, southern region, Saudi Arabia that are currently or previously were used MTX. All the patients included fulfilled the 1987 revised American Rheumatism Association criteria for classification of RA. Medical records for 200 RA patients were chosen through convenience method then they reviewed and analyzed. Result: A total of 200 RA patients were participated, 169 (84.5%) were female and 31 (15.5%) were male. Their ages ranged from 12 to 80 years with a mean of 45.07 and standard deviation 14.37 years. 67 (33.5%) of patients and their disease duration was 10 years and more. 147 (73.5%) of our patients were using MTX and 53 (26.5%) were not. Out of 147 patients, 24 (27%) of them did not take MTX regularly due to different causes. The most common side effects were stomach ache as same as indolence and sloth. There is no statistical association between sex, education level and duration of disease and discontinuation at P=0.05. Conclusion: The study concluded a low rate of drug discontinuation due to adverse effects; MTX seems to be a safe drug for longterm use in RA patients. More attempts should be done to minimize side effects and discontinuation of MTX, to get the benefits of drug considered as the cornerstone in RA treatment. dr.majedalsubaie@gmail.com